A Conformationally-Locked P-Hydroxybenzylidene Imidazolinone Derivative for Detecting Aβ42 Aggregation

Anyang Sun,Han Sun,Gulziba Anwar,Xiuhong Lu,Jinwu Yan
DOI: https://doi.org/10.1016/j.bmcl.2023.129576
IF: 2.94
2024-01-01
Bioorganic & Medicinal Chemistry Letters
Abstract:Alzheimer's disease (AD) is a common type of neurodegenerative disease, which can only be symptomatically relieved but does not yet have a cure. Among the different A beta species, amyloid-beta (42) (A beta(42)) aggregates are proposed to be more neurotoxic than that of A beta(40), and oligomeric A beta(42) is thought to play a harmful role in the pathophysiology of AD. Therefore, the detection of A beta(42) aggregation is very meaningful in the AD field. We herein report a conformationally-locked p- hydroxybenzylidene imidazolinone derivative, BDI, which exhibits selectivity and specificity towards A beta(42) aggregation and remarkable fluorescent enhancement with a large Stokes shift (more than 100 nm). In the fluorescent co-localization study, BDI can sensitively detect a large population of A beta(42) aggregation over that of A beta(40) in the brain tissues of AD transgenic mouse models. Therefore, this new probe could provide a useful tool for the rapid detection of important A beta species in AD.
What problem does this paper attempt to address?